0.8356USD-11.00%Mkt Cap: 10.35M USDP/E: —Last update: 2026-06-01
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead prod…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap10.35M USD
Enterprise Value-34.69M USD
Revenue (TTM)123.30K USD
Gross Profit-6.92M USD
Net Income (TTM)-12.60M USD
Revenue/Share0.0140 USD
Last Price0.8356 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.13
PEG—
EV/EBITDA2.76
EV/Revenue-281.32
P/S89.64
P/B0.26
EPS (TTM)-1.49
EPS (Forward)-0.79
52W Range
0.548017% of range2.220
52W High2.220 USD
52W Low0.5480 USD
Profitability
Gross Margin0.00%
Oper. Margin-10202.01%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-101.27%
ROA-79.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.89M USD
CapEx (TTM)—
FCF Margin-4548.21%
FCF Yield-54.20%
Net Debt-46.47M USD
Net Debt/EBITDA3.70
Balance Sheet
Debt/Equity—
Current Ratio8.92
Quick Ratio8.77
Book Value/Sh3.471 USD
Cash/Share3.752 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateFeb 13, 2023
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)4.300 USD
Target Range1.200 USD – 6.000 USD
# Analysts4
Ownership
Shares Out.12.38M
Float8.57M
Insiders11.56%
Institutions18.13%
Short Interest
Short Ratio0.6d
Short % Float1.27%
Short % Out.1.19%
Shares Short147.56K
Short (prev mo.)109.91K
Technical
SMA 500.8384 (-0.3%)
SMA 2001.078 (-22.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)187.37K
Avg Vol (10d)161.22K
Technical Indicators
RSI (14)55.0
MACD0.0205
MACD Signal0.0182
MACD Hist.+0.0023
BB Upper0.9958 USD
BB Middle0.8953 USD
BB Lower0.7947 USD
BB Width22.46%
ATR (14)0.0830 USD
Vol Ratio (20d)0.27x